JPMorgan Chase & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$672M Sell
2,062,008
-156,864
-7% -$51.2M 0.04% 331
2025
Q1
$599M Sell
2,218,872
-31,188
-1% -$8.42M 0.04% 325
2024
Q4
$529M Buy
2,250,060
+87,116
+4% +$20.5M 0.04% 346
2024
Q3
$595M Buy
2,162,944
+390,073
+22% +$107M 0.05% 322
2024
Q2
$431M Buy
1,772,871
+24,682
+1% +$6M 0.04% 390
2024
Q1
$261M Sell
1,748,189
-1,267,952
-42% -$189M 0.02% 534
2023
Q4
$577M Sell
3,016,141
-70,705
-2% -$13.5M 0.06% 299
2023
Q3
$547M Sell
3,086,846
-46,128
-1% -$8.17M 0.06% 276
2023
Q2
$595M Buy
3,132,974
+38,240
+1% +$7.26M 0.06% 273
2023
Q1
$620M Sell
3,094,734
-32,960
-1% -$6.6M 0.08% 259
2022
Q4
$743M Buy
3,127,694
+582,662
+23% +$138M 0.1% 205
2022
Q3
$509M Buy
2,545,032
+261,395
+11% +$52.3M 0.07% 249
2022
Q2
$333M Sell
2,283,637
-635,378
-22% -$92.7M 0.05% 346
2022
Q1
$477M Sell
2,919,015
-53,070
-2% -$8.67M 0.06% 297
2021
Q4
$504M Buy
2,972,085
+526,426
+22% +$89.3M 0.06% 309
2021
Q3
$462M Sell
2,445,659
-142,851
-6% -$27M 0.06% 314
2021
Q2
$439M Buy
2,588,510
+410,109
+19% +$69.5M 0.05% 343
2021
Q1
$308M Sell
2,178,401
-126,049
-5% -$17.8M 0.04% 420
2020
Q4
$300M Buy
2,304,450
+29,185
+1% +$3.79M 0.04% 382
2020
Q3
$330M Buy
2,275,265
+52,378
+2% +$7.6M 0.06% 308
2020
Q2
$329M Buy
2,222,887
+1,380,042
+164% +$204M 0.06% 286
2020
Q1
$91.7M Buy
842,845
+250,331
+42% +$27.2M 0.02% 558
2019
Q4
$68.2M Sell
592,514
-55,922
-9% -$6.44M 0.01% 737
2019
Q3
$52.1M Sell
648,436
-16,401
-2% -$1.32M 0.01% 845
2019
Q2
$47.3M Buy
664,837
+12,898
+2% +$917K 0.01% 898
2019
Q1
$60.9M Buy
651,939
+206,129
+46% +$19.3M 0.01% 790
2018
Q4
$32.5M Sell
445,810
-540,036
-55% -$39.4M 0.01% 988
2018
Q3
$86.3M Buy
985,846
+352,794
+56% +$30.9M 0.02% 708
2018
Q2
$62.3M Buy
633,052
+577,251
+1,034% +$56.9M 0.01% 783
2018
Q1
$6.65M Buy
55,801
+42,382
+316% +$5.05M ﹤0.01% 2020
2017
Q4
$1.71M Sell
13,419
-1,614
-11% -$205K ﹤0.01% 2805
2017
Q3
$1.78M Sell
15,033
-40,233
-73% -$4.76M ﹤0.01% 2684
2017
Q2
$4.41M Sell
55,266
-7,720
-12% -$616K ﹤0.01% 2191
2017
Q1
$3.23M Buy
62,986
+6,678
+12% +$342K ﹤0.01% 2345
2016
Q4
$2.11M Buy
56,308
+29,712
+112% +$1.11M ﹤0.01% 2648
2016
Q3
$1.8M Sell
26,596
-4,348
-14% -$295K ﹤0.01% 2512
2016
Q2
$1.72M Sell
30,944
-7,218
-19% -$401K ﹤0.01% 2523
2016
Q1
$2.4M Buy
38,162
+450
+1% +$28.2K ﹤0.01% 2300
2015
Q4
$3.55M Sell
37,712
-116,201
-75% -$10.9M ﹤0.01% 2117
2015
Q3
$12.4M Sell
153,913
-138,689
-47% -$11.1M ﹤0.01% 1433
2015
Q2
$35.1M Sell
292,602
-233,727
-44% -$28M 0.01% 966
2015
Q1
$55M Sell
526,329
-122,099
-19% -$12.7M 0.01% 798
2014
Q4
$62.9M Buy
648,428
+143,864
+29% +$14M 0.01% 768
2014
Q3
$39.4M Sell
504,564
-5,289
-1% -$413K 0.01% 928
2014
Q2
$32.2M Buy
509,853
+99,216
+24% +$6.27M 0.01% 1055
2014
Q1
$27.6M Buy
410,637
+124,155
+43% +$8.34M 0.01% 1118
2013
Q4
$18.4M Sell
286,482
-14,210
-5% -$914K 0.01% 1294
2013
Q3
$19.2M Buy
300,692
+31,105
+12% +$1.99M 0.01% 1275
2013
Q2
$8.36M Buy
+269,587
New +$8.36M ﹤0.01% 1649